The evolving healthcare landscape brings new challenges and opportunities to the industry each year. However, many leaders say there are certain aspects of ASC management that are pivotal to success.
Since 1995, the FDA has cleared 521 artificial intelligence-enabled medical devices through 510(k) clearance, de novo requests or approved premarket approval applications.
Tallahassee-based Florida State University has entered a scientific collaboration with Lento Bio, a pharmaceutical company developing medications for presbyopia.
After a year of phone calls and appeals, a patient of a Virginia ASC has had her medical debt canceled after Medicare refused to cover a procedure that was moved from a hospital to an ASC, according to a Feb. 6 report from The Roanoke Times.